Screener
Kura Oncology KURA Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $70.24M-14.3% | $39.08M-23.8% | $149.1M-33.6% | $95.29M+92.6% | $81.95M+81.4% | ||
| $448.78M-18.2% | $541.74M-10.7% | $518.14M+3.0% | $454.38M+12.0% | $548.78M+23.0% | ||
| $9.45M+107% | $9.35M-80.8% | $8.8M+327% | $35.94M+6,878% | $4.57M+788% | ||
| $2.49M+2,307% | $843K+716% | $413K— | $103.25K— | $103.25K— | ||
| $559.44M-15.2% | $623.78M-13.9% | $708.66M-4.9% | $620.66M+34.0% | $660.08M+32.1% | ||
| $7.59M+93.9% | $7.61M+224% | $7.86M+367% | $7.4M+463% | $3.91M+157% | ||
| $587.79M-13.9% | $652.55M-12.3% | $738.36M-2.9% | $649.38M+35.6% | $682.43M+32.5% | ||
| $2.39M-95.5% | $7.04M-84.4% | $5.02M+242% | $66.79M+80.7% | $52.93M+70.0% | ||
| $55.48M+12.2% | $47.7M+16.8% | $48.98M+102% | $48.75M— | $49.44M— | ||
| $4.22M+35.5% | —— | $0-100% | $4.34M+153% | $3.11M+267% | ||
| $118.19M+10.3% | $101.5M+13.1% | $116.97M+48.6% | $121.3M+200% | $107.17M+220% | ||
| $5.57M-14.4% | $9.75M+27.4% | $9.71M+40.4% | $5.34M-31.2% | $6.51M-24.1% | ||
| $539.36M+43.1% | $544.67M+43.6% | $564.23M+62.8% | $406.84M+639% | $376.94M+669% | ||
| $9K0.0% | $9K+12.5% | $9K+12.5% | $9K+12.5% | $9K+12.5% | ||
| -$1.32B-29.1% | -$1.25B-30.9% | -$1.17B-31.1% | -$1.09B-24.8% | -$1.02B-24.0% | ||
| $48.43M-84.1% | $107.88M-70.4% | $174.14M-57.9% | $242.54M-42.8% | $305.49M-34.5% | ||
| $587.79M-13.9% | $652.55M-12.3% | $738.36M-2.9% | $649.38M+35.6% | $682.43M+32.5% |
FAQ
- What are Kura Oncology's total assets?
- Kura Oncology (KURA) holds $587.8M in total assets, down 13.9% year over year.
- How much debt does Kura Oncology have?
- Kura Oncology carries $24.5M in total debt against $48.4M of shareholders' equity, a debt-to-equity ratio of 0.50.
- How much cash does Kura Oncology have?
- Kura Oncology holds $70.2M in cash and equivalents.
- Can Kura Oncology cover its short-term obligations?
- Its current ratio is 4.73 — current assets exceed current liabilities.
- Where does Kura Oncology's balance sheet data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
